The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics

MLA

Joseph Peuskens, et al. “The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.” CNS Drugs, vol. 29, Aug. 2015, pp. 637–58. EBSCOhost, https://doi.org/10.1007/s40263-015-0269-4.

APA

Joseph Peuskens, Marc De Hert, Kristof Vansteelandt, Paul Geerts, Johan Detraux, & Jan Sermon. (2015). The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics. CNS Drugs, 29, 637–658. https://doi.org/10.1007/s40263-015-0269-4

Chicago

Joseph Peuskens, Marc De Hert, Kristof Vansteelandt, Paul Geerts, Johan Detraux, and Jan Sermon. 2015. “The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.” CNS Drugs 29 (August): 637–58. doi:10.1007/s40263-015-0269-4.